William Blair & Company’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,000
| Closed | -$364K | – | 1879 |
|
|
2024
Q3 | $364K | Sell |
20,000
-5,432
| -21% | -$98.8K | ﹤0.01% | 1221 |
|
|
2024
Q2 | $483K | Hold |
25,432
| – | – | ﹤0.01% | 1106 |
|
|
2024
Q1 | $549K | Sell |
25,432
-116
| -0.5% | -$2.51K | ﹤0.01% | 1061 |
|
|
2023
Q4 | $444K | Sell |
25,548
-13,438
| -34% | -$233K | ﹤0.01% | 1103 |
|
|
2023
Q3 | $383K | Hold |
38,986
| – | – | ﹤0.01% | 1137 |
|
|
2023
Q2 | $214K | Sell |
38,986
-2,277
| -6% | -$12.5K | ﹤0.01% | 1387 |
|
|
2023
Q1 | $256K | Sell |
41,263
-624
| -1% | -$3.87K | ﹤0.01% | 1304 |
|
|
2022
Q4 | $639K | Hold |
41,887
| – | – | ﹤0.01% | 966 |
|
|
2022
Q3 | $420K | Sell |
41,887
-9,288
| -18% | -$93.1K | ﹤0.01% | 1107 |
|
|
2022
Q2 | $606K | Sell |
51,175
-4,950
| -9% | -$58.6K | ﹤0.01% | 1004 |
|
|
2022
Q1 | $1.07M | Buy |
56,125
+99
| +0.2% | +$1.88K | ﹤0.01% | 901 |
|
|
2021
Q4 | $1.34M | Buy |
56,026
+11,582
| +26% | +$277K | ﹤0.01% | 850 |
|
|
2021
Q3 | $911K | Buy |
+44,444
| New | +$911K | ﹤0.01% | 967 |
|